Heartbeam

Heartbeam Liabilities

The The Liabilities of Heartbeam (BEAT) as of Nov 4, 2026 is 3.24 M USD. In the previous year, The Liabilities was 1.62 M USD — a change of 99.75% (higher).

Liabilities

3.24 MUSD

YoY

99.75%

Last updated:

In 2025, Heartbeam's total liabilities amounted to 3.24 M USD, a 99.75% difference from the 1.62 M USD total liabilities in the previous year.

The Heartbeam Liabilities history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Liabilities
Date
Liabilities
Jan 1, 2018
276.32 M USD
Jan 1, 2019
3.73 M USD
Jan 1, 2020
4.84 M USD
Jan 1, 2021
588,000.00 USD
Jan 1, 2022
1.67 M USD
Jan 1, 2023
1.19 M USD
Jan 1, 2024
1.62 M USD
Jan 1, 2025
3.24 M USD
The Heartbeam Liabilities history
YEARLiabilitiesYoY
3.24 MUSD+99.75%
1.62 MUSD+35.85%
1.19 MUSD-28.29%
1.67 MUSD+183.16%
588,000.00USD-87.84%
4.84 MUSD+29.51%
3.73 MUSD-98.65%
276.32 MUSD+0.53%
274.86 MUSD+357.56%
60.07 MUSD+24.58%
48.22 MUSD-21.09%
61.10 MUSD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Heartbeam Stock analysis

What does Heartbeam do? HeartBeam, Inc. generates revenue through its proprietary VECG technology platform, which includes two patented products: HeartBeam AIMI and HeartBeam AIMIGo. HeartBeam AIMI is software designed for acute care settings, offering 3D comparison of baseline and symptomatic 12-lead ECG to detect heart attacks. HeartBeam AIMIGo is a credit card-sized 12-lead ECG device paired with a smartphone app and cloud-based diagnostic software for remote heart attack detection. The company targets healthcare facilities and remote monitoring segments, focusing on cardiovascular diagnostic solutions for both in-hospital and out-of-hospital settings. HeartBeam AIMI is sold to acute care providers such as hospitals and emergency departments, while HeartBeam AIMIGo serves patients and remote healthcare services seeking continuous cardiac monitoring. The firm's revenue streams derive from the commercialization of these two products, leveraging its patented VECG technology to provide higher resolution ambulatory ECG solutions. The company's focus on detecting and monitoring cardiac disease outside traditional healthcare facilities drives its product development and sales strategy. HeartBeam Inc. operates in the cardiovascular diagnostic technology sector, with its products designed to enable cardiac disease detection both inside and outside healthcare facilities. The firm's VECG platform allows for 3D vector imaging of cardiac electrical activity, enhancing diagnostic capabilities beyond standard ECG methods. Revenue is generated through the sale of software, devices, and cloud-based diagnostic systems tailored to specific healthcare environments and remote monitoring needs. Heartbeam is one of the most popular companies on Eulerpool.

Liabilities Details

Assessing Heartbeam's Liabilities

Heartbeam's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating Heartbeam's financial stability, operational efficiency, and long-term viability.

Year-to-Year Comparison

By comparing Heartbeam's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.

Impact on Investments

Heartbeam's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.

Interpreting Liability Fluctuations

Shifts in Heartbeam’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.

Frequently Asked Questions about Heartbeam stock

The Liabilities of Heartbeam is 3.24 M USD in 2025.

The Liabilities of Heartbeam changed from 1.62 M USD to 3.24 M USD, representing a 99.75% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of The Liabilities Heartbeam since 2006 – with annual values, charts, and detailed analysis.

The Liabilities's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track The Liabilities's Heartbeam historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Heartbeam

All Key Metrics — Heartbeam